GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Interest Expense

Toleranzia AB (OSTO:TOL) Interest Expense : kr-0.09 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Toleranzia AB's interest expense for the three months ended in Dec. 2023 was kr -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Toleranzia AB's Operating Income for the three months ended in Dec. 2023 was kr -2.46 Mil. Toleranzia AB's Interest Expense for the three months ended in Dec. 2023 was kr -0.01 Mil. Toleranzia AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Toleranzia AB Interest Expense Historical Data

The historical data trend for Toleranzia AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Interest Expense Chart

Toleranzia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 - -0.04 -0.02 -0.10

Toleranzia AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.07 -0.01

Toleranzia AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Toleranzia AB  (OSTO:TOL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Toleranzia AB's Interest Expense for the three months ended in Dec. 2023 was kr-0.01 Mil. Its Operating Income for the three months ended in Dec. 2023 was kr-2.46 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was kr0.85 Mil.

Toleranzia AB's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Toleranzia AB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Toleranzia AB (OSTO:TOL) Business Description

Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.